Mouse ILC (like most conditional mouse models of human breast cancer) is an ER negative tumor type [10, 11], and as such models a minority of human ILC that is either ER negative or non-responsive to ER antagonists treatment. This evidence concerns the gene CCL27 and breast carcinoma.